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One of the most important advances made in translational
research is in the field of ocular surface reconstruction using
cell therapy [1-3]. This technology owes its success not only
to the surgical advances but also to the increasing amount of
knowledge  pertaining  to  the  location,  characteristics  and
functioning of Limbal stem cells (LSC) [4-6]. In the normal
uninjured state, LSC are mitotically quiescent and maintained
in a specialized limbal stromal microenvironment or “niche.”
However,  upon  corneal  epithelial  wounding,  stem  cells
located in the limbus proliferate to generate more stem cells
and  transient  amplifying  cells  to  replace  the  damaged
epithelium.  It  is  generally  agreed  that  the  LSC  are
characterized  by  special  location  in  the  limbus,  clonality,
cytokeratin profile, transformation-related protein 63 (p63)
delta  isomers,  and  ATP-binding  cassette  sub-family  G
member 2 (ABCG2) expression [7-9]. It is well established
that the niche plays an important role in the maintenance of
stem cell properties in several tissues and this is expected to
be true in the case of the LSC niche as well [10-13]. Some of
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the assumed factors for niche regulation include proximity to
vasculature [14]; the basement membrane composition with
respect  to  specific  isoforms  of  collagen  IV,  laminin  and
fibronectin [15]; and the presence of limbal fibroblasts in the
underlying stroma, which produce various cytokines [16].
We had earlier reported the presence of spindle shaped
cells in extended limbal explant cultures, which bear a striking
resemblance to the mesenhcymal stem cells derived from
bone  marrow  (MSC-BM),  which  we  had  referred  to  as
mesenhcymal  like  cells  from  limbus  (MC-L)  [17].
Interestingly,  limbal  fibroblast-like  cells  have  also  been
reported  to  have  stem  cell  like  properties  [18]  and  their
conditioned media has been reported to foster conversion of
human embryonic stem cells into corneal epithelial-like cells
[19].
Several groups have reported the gene expression profile
of limbal and corneal epithelial cells that has significantly
contributed to the understanding of several cellular pathways
and intrinsic factors that underpin the phenotypic difference
between the two cell types [20-22]. These studies and the
study by Zhou et al. [23], have used the native corneal and
limbal tissue to derive the gene expression profile. However
the  gene  expression  profile  of  the  cultured  human  limbal
epithelial and stromal cells cultured cells obtained from the
native limbal tissue that is used for clinical transplantation to
regenerate the ocular surface has not been addressed until
now. In the present study, we evaluated the transcriptome of
the limbal explant culture derived epithelial and mesenchymal
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Purpose: Limbal stem cell deficiency is a challenging clinical problem and the current treatment involves replenishing
the depleted limbal stem cell (LSC) pool by either limbal tissue transplantation or use of cultivated limbal epithelial cells
(LEC). Our experience of cultivating the LEC on denuded human amniotic membrane using a feeder cell free method,
led to identification of mesenchymal cells of limbus (MC-L), which showed phenotypic resemblance to bone marrow
derived  mesenchymal  stem  cells  (MSC-BM).  To  understand  the  transcriptional  profile  of  these  cells,  microarray
experiments were carried out.
Methods: RNA was isolated from cultured LEC, MC-L and MSC-BM and microarray experiments were carried out by
using Agilent chip (4×44 k). The microarray data was validated by using Realtime and semiquntitative reverse transcription
polymerase chain reaction.
Results: The microarray analysis revealed specific gene signature of LEC and MC-L, and also their complementary role
related to cytokine and growth factor profile, thus supporting the nurturing roles of the MC-L. We have also observed
similar and differential gene expression between MC-L and MSC-BM.
Conclusions: This study represents the first extensive gene expression analysis of limbal explant culture derived epithelial
and mesenchymal cells and as such reveals new insight into the biology, ontogeny, and in vivo function of these cells.like cells by microarray and identified expression of unique
genes and biologic pathways that characterize both these cell
types. To evaluate our hypothesis that the MC-L possibly act
as one of the “niche” derived intrinsic feeder cells in the feeder
cell free method of limbal explants culture, we compared the
profile of these cells to that of the MSC-BM, which form the
supporting niche for the hematopoietic system.
METHODS
All the procedures, recruitment of patients and the protocol
were approved by the Institutional Review Board (L.V. Prasad
Eye  Institute  IRB,  Hyderabad,  India)  and  the  research
followed the tenets of the declaration of Helsinki.
Establishment of cell cultures: In an ongoing clinical
trial,  which  was  approved  by  the  IRB,  limbal  epithelial
cultures were established from limbal biopsies as described in
our  previous  publications  [2,3,17].  Briefly,  less  than
1×2 mm2 piece of limbal biopsy was obtained from the limbal
region which included the epithelium as well as 0.5 mm of
stromal tissue. Limbal epithelial cultures were established on
de-epitheliazed human amniotic membrane (dhAM) with the
basement  membrane  side  up,  in  a  feeder  cell-free  culture
system.  Cultures  were  established  in  duplicates  for  each
clinical  sample  of  which  one  culture  was  used  for
transplantation (after 10–14 days in culture) while the other
culture used for experiments. A total of 25 samples were used
in this study of which, 3 samples were used for RNA isolation
and the remaining were cultured further. The limbal explants
cultures in the duplicate plates were incubated for 2–3 weeks
more to propogate the adherent spindle cells in the bottom of
the Petri dish, beyond the area of amniotic membrane, which
contained epithelial cells (n=22). These plates adherent cells
(epithelial and spindle cells) were then trypsinized and plated
on a T25 flask (Thermofisher Scientific, Roskilde, Denmark)
in  DMEM  medium  supplemented  with  10%  fetal  bovine
serum (FBS; Sigma-Aldrich Inc., St. Louis, MO). The non-
adherent  epithelial  cells  suspended  in  the  medium  were
removed  by  changing  the  medium.  These  cultures  were
maintained at 37 °C and 5% CO2 in humidified incubator
(BINDER  GmbH,  Tuttlingen,  Germany).  When  the  cells
reached 80%–90% confluence, cultures were harvested with
0.25%  trypsin  (Sigma-Aldrich)  in  1mM  EDTA  solution
(Sigma-Aldrich).  MSC-BM  cells  were  obtained  using  a
previously described protocol [17]. Briefly, human MSC-BM
cultures  were  established  from  bone  marrow  aspirates  of
healthy donors after obtaining informed consent. The bone
marrow mononuclear cells (BMMNCs) were separated using
Ficoll-Hypaque  gradient  at  400×  g  for  30  min.  The
mononuclear cells were then plated at a density of 1×107 cells
in Dulbecco's Modified Eagle's Medium (DMEM; Sigma-
Aldrich Chemie, Steinheim, Germany) supplemented with
10%  FBS.  When  cultures  reached  confluence,  cells  were
passaged using trypsin-EDTA in line 100.
Immunocytochemical analysis—Immunocytochemical
analysis was performed as previously described [17]. Briefly,
cells were incubated with primary antibodies for vimentin,
ATP-binding  cassette  subfamily  G  member  2  (ABCG2),
Cytokeratin 14 (KRT14), Cytokeratin 3/12 (KRT3/12), E-
cadherin  (CDH1),  cytokeratin  19  (KRT19),  cluster  of
differentiation 45 (CD45), and nestin (Chemicon, Billerica,
MA). Double immunostaining was performed for vimentin
and paired box gene 6 (PAX-6). Following incubation with
secondary antibodies (conjugated to Fluorscein Isothiocynate
(FITC) or Tetramethyl Rhodamine Isothiocynate (TRITC),
the nucleus was counterstained with propidium iodide (PI).
The stained preparations were screened with a laser scanning
confocal microscope (LSM 510; Carl Zeiss, Jena, Germany)
using a fluorescent light source.
Flow  cytometry  analysis—MC-L  were  characterized
for the expression of CD44-PE (Phycoerythrin), CD90-FITC,
CD13-FITC, human leukocyte antigen (HLA-ABC-PE and
HLA-DR-PE),  CD10-PE,  CD40-FITC,  CD11b-FITC,
CD40L-APC (Allophycocyanin), CXC chemokine receptor 4
(CXCR4)  –APC  (eBioscienceTM,  San  Diego,  CA)  CD34-
FITC,  CD138-PerCP  (Peridinin  Chlorophyll  Protein
Complex;  BD  Pharmingen™,  San  Diego,  CA)  markers.
Briefly, a single cell suspension of 0.5 to 1×106 cells obtained
in 100 µl of PBS (phosphate buffered saline) containing 0.1%
sodium  azide  and  2%  FBS.  These  were  incubated  with
saturating concentrations of the respective primary antibodies
or conjugated antibodies for 45 min. After three washes, the
cells were centrifuged at 200× g for 5 min and resuspended in
ice-cold PBS. Fluorescence was evaluated by BD-FACS Aria
(BD Biosciences) and data were analyzed by using FACS
Diva software. Corresponding isotype controls were included
in each experiment and specific staining was measured from
the cross point of the isotype with a specific antibody graph.
A  total  of  20,000  events  were  acquired  to  determine  the
positivity of different cell surface markers used.
Total RNA isolation: Total RNA was extracted from each
sample (n=3 for LEC, MC-L, and MSC-BM) with Trizol
(Invitrogen,  Carlsbad,  CA)  and  purified  using  RNAeasy
Columns  (Qiagen  GmbH,  Hilden,  Germany,).  RNA  was
quantitated  by  NanoDrop  ND-1000  (Thermo  Scientific,
Wilmington  DE)  and  the  quantity  and  integrity  was
established by resolving on 0.8% formaldehyde agarose gels.
Expression  profiling  of  genes  by  microarray
experiments: Microarray experiments were performed using
Agilent 4×44k oligonucleotide arrays. These arrays cover the
entire genome. For labeling reaction, 500 ng of RNA from
LEC, MC-L, and MSC-BM was used (n=2 of each LEC, MC-
L, and MSC-BM). Labeling was done using the Quick Amp
labeling kit (Agilent technologies, Santa Clara, CA) as per the
manufacturer’s protocol. Briefly, using T7 promoter element
coupled  oligodT  primer,  cDNA  was  generated  and  from
cDNA,  labeled  cRNA  was  generated  via  an  in  vitro
transcription reaction using T7 RNA polymerase and Cy3 (for
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cRNA  (825  ng)  of  the  respective  sample  was  used  for
hybridization in the following combinations - LEC (Cy3) and
MC-L (Cy5), LEC (Cy3) and MSC-BM (Cy5) and MC-L
(Cy3) and MSC-BM (Cy5). Hybridization was performed for
17 h, rotating at a speed of 10 rpm at 65 °C in an hybridization
oven (Agilent Technologies).
Microarray image and data analysis: Microarray image
analysis was done using Feature extraction version 9.5.3.1
(Agilent  Technologies)  and  data  analysis  was  done  using
Gene  Spring  version  10  (Agilent  Technologies).  The
background corrected intensity values were used for analysis.
Normalization was done using LOWESS algorithm. Similarly
expressed  genes  were  filtered  on  the  basis  of  standard
deviation between two biologic replicates with the cut off of
less than one. Fold changes were calculated and genes with
more than twofold difference were selected.
Validation of microarray using aemi quantitative RT–
PCR and Real-time-PCR: To confirm the gene expression
profile determined by microarray, several selected genes were
subjected to RT–PCR analysis, using total RNAs derived from
the two independent samples of LEC, MC-L, and MSC-BM
that were used for the microarray experiments, as well as an
additional  pair  of  LEC,  MC-L,  and  MSC-BM  samples.
Ribosomal protein large 35 (RPL35) a, a ribosomal protein
served as an internal control. A 2 µg quantity of RNA was
reverse  transcribed  using  a  cDNA  synthesis  kit  (Applied
Biosystems, Foster City, CA) and 1/100th of the reaction was
used per 20 µl PCR reaction. PCR reactions were performed
with  DyNAZYME  master  mix  (Finnzymes  Oy,  Espoo,
Finland). The PCR products were resolved on a 2% agarose
gel  containing  ethidium  bromide.  Real-Time  PCR
quantitation  was  performed  in  an  ABI  prism  7900  HT
sequence  detection  system  and  analyzed  with  SDS  2.1
software (Applied Biosystems). The reactions were identical
to  those  described  above,  except  that
DyNAMOTMSYBERgreen 2× mix (Finnzymes Oy) was used
in place of DyNAZYME MIX. The sequences of primers are
shown in Table 1. Amplification of RPL35a was performed
for  each  cDNA  (in  triplicate)  for  normalization  of  RNA
content. Threshhold cycle number (Ct) of amplification in
each  sample  was  determined  by  ABI  Prism  Sequence
Detection System software (Applied Biosystems). Relative
mRNA abundance was calculated as the average for Ct for
amplification of a gene-specific cDNA minus the average Ct
for RPL35a and fold change over control has been calculated
as follows:
Δct = ctgene − ctRPL
ΔΔctt =Δct(one cell type)   –Δct(another cell type)
Fold Change = 2
−ΔΔct
Three individual gene-specific values thus calculated were
averaged to mean±standard deviation, and fold change was
expressed as log 2 ratios.
RESULTS
Establishment  of  cell  cultures:  Spindle  cell  cultures  were
established from extended limbal explant cultures after 2 to 3
weeks of culture. Under a phase contrast microscope the cells
appeared fibroblastic, elongated, and spindle shaped and few
cells were large and flat with a single nucleus. These cells
demonstrated the ability to form colonies with the occasional
cell  sphere  formation  giving  the  impression  of  embryoid
bodies (Figure 1).
Characteristics  of  limbal  explant  culture  derived
mesenchymal  cells:  The  LEC  on  immunocytochemical
analysis, showed immunoreactivity toward ABCG2, CK3/
CK12,  CK14,  PAX-6,  CDH1,  and  vimentin.  MC-L  were
found to be immunoreactive for vimentin and nestin and were
negative  cytokeratin  3/12  (KRT3/12),  cytokeratin  14
(KRT14), and CD45 (Figure 2A-L).
Flowcytometry analysis of MC-L revealed expression of
CD90+CD44 (Figure 2N [Q2=98.4%]), CD13 (Figure 2V
[Q1–3=86.4%]), and HLA-ABC (Figure 2P [Q1=91.1%]) and
were  negative  or  weak  expression  for  CD34  (Figure  2Q
[Q4=0.0%]),  CD10  (Figure  2Q  [Q1=0.1%),  CD34+CD10
(Figure  2Q  [Q2=0.0%])  CD11b  (Figure  2P  [Q4=0.0%]),
CD40  (Figure  2O  [Q4=0.0%]),  CD40L  (Figure  2T  [Q4–
1=0.0%]),  CD138  (Figure  2V  [Q4–3=0.0%]),  CXCR4
(Figure  2S  [Q4–1=0.0%])  and  HLA-DR  (Figure  2O
[Q1=0.1%]) expression (Figure 2M-V).
Microarray data analysis: In this study two different samples
of LEC, MC-L, and MSC-BM were labeled using (Cy3 and
Cy5) dyes and competitive hybridization was performed. The
data has been deposited in NCBI’s Gene Expression Omnibus
(GEO) with GEO series accession number (GSE16763). The
fold change was expressed as average of two different biologic
samples.  Analysis  of  the  data  considering  a  threefold
difference, suggested differential expression of 3,484 genes
between LEC and MC-L; 1,579 genes between MC-L, and
MSC-BM  and  4,837  between  LEC  and  MSC-BM.  The
differentially/highly  expressed  genes  in  LEC,  MC-L,  and
MSC-BM are shown in Table 2. The groups were segregated
based on the average fold expression toward one lineage as
compared to other, i.e genes that are highly representative of:
a) LEC≥25 fold expression as compared to MC-L and MSC-
BM; b) MC-L≥15 fold expression as compared to LEC and
MSC-BM; c) MSC-BM≥20 fold expression as compared to
LEC and MC-L; d) MC-L and MSC-BM≥20 fold expression
compared  to  LEC;  e)  LEC  and  MC-L≥10  expression
compared to MSC-BM.
Some of the highly expressed genes in LEC include the
CD24 (48 and 155 fold overexpression compared to MSC-BM
and  MC-L,  respectively),  FOXA1  (27  and  631  fold
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respectively) and KRT13 (11 and 15-fold), LAMA3 (7.4 and
7.3), ITGA6 (22 and 10) and CDH3 (6.0 and 7.4). To explore
the interdependence of LEC and MC-L, we looked at the
growth factor and cytokine profile of these cells (Table 3).
LEC  showed  high  expression  of  growth  factors  like
transforming  growth  factor  alpha  (TGF−α),  Amphiregulin
(AREG), epiregulin (EREG), hepatocyte binding epidermal
growth  factor  (HB-EGF),  growth  factor  receptor-bound
protein 14 (GRB14), fibroblast growth factor 11 (FGF11), and
cytokines like chemokine (C-X-C motif) ligand 1 (CXCL1),
CXCL2. The MC-L showed high expression of growth factors
like FGF7, FGF2 and cytokine CXCL12.
TABLE 1. SEQUENCE OF THE PRIMER USED FOR RT–PCR AMPLIFICATION OF SELECTED GENES TO SUBSTANTIATE THE RESULTS OBTAINED BY MICROARRAY.
Sample
number
Gene name Forward primer (5′→3′) Reverse primer (5′→3′) Product
length (bp)
1 Vascular Endothelial
Growth factor A
(VEGF-A)
ATGCGGATCAAACCTCACC ATCTGGTTCCCGAAACCCTG
  183      358
  165      304
  148      269
  121      172
2 Fibroblast Growth
Factor 2 (FGF2)
GGAGAAGAGCGACCCTCAC GTGCCACATACCAACTGGTG 221
3 (Angiopoietin 1
(Ang-1)
CCCAGAAACTTCAACATCTGG GGACTGTGTCCATCAGCTC 537
4 Transforming growth
factor, beta 1
(TGFB1)
GACTACTACGCCAAGGAGGTC TCAACCACTGCCGCACAACTC 332
5 Nestin (NES) CACCTGTGCCAGCCTTTCTTAA CCACCGGATTCTCCATCCTTA 361
6 Neuron-specific class
III beta-tubulin
(Tuj1)
TCAAGCGCATCTCCGAGCAG ACCGTAAAACGTCAGGCCTGGAG 444
7 Collagen 1 alpha 1 TCCCCAGCCACAAAGAGTCTA TTTCCACACGTCTCGGTCA 201
8 Vimentin` CAGGAACAGCATGTCCAAATCG TGTACCATTCTTCTGCCTCCTGC 127
9 S100A2 GATCCATGATGTGCAGTTCTCT GTTCTGCTTCAGGGTCGGT 310
10 RPL35A GAACCAAAGGGAGCACACAG CAATGGCCTTAGCAGGAAGA 236
11 PAX-6 GAATCAGAGAAGACAGGCCA GGTAGGTATCATAACTCCG 302
12 S100A4 GATGAGCAACTTGGACAGCAA CTGGGCTGCTTATCTGGGAAG 123
13 E-cadherin AAGGTGACAGAGCCTCTGGATAGA TCTGATCGGTTACCGTGATCAA 124
14 CD24 AACTAATGCCACCACCAAGG CCTGTTTTTCCTTGCCACAT6 188
15 PBX-1 ACCCTTCGCCATGTTATCAG ATTGCTGGGAGATCAGTTGG 189
16 OTX-1 CTCCACCCAGCTGTTAGCAT CGCATGAAGATGTCAGGGTA 221
17 FOXA1 AGGGCTGGATGGTTGTATTG AGGCCTGAGTTCATGTTGCT 150
18 SHC3 GACATCTACAGCACGCCAGA CAAGGGCTGGTTCTTGAGAG 186
19 FOXF1 TTGGCAATATTTGCCGTGTA CTGCACTCTAGCAGCCAAAA 209
20 CDH6 TCGAGAAAACAGGGAGCAGT CGGTGGAGAAGATTCAGGAG 175
21 CDH11 GTGCCTGAGAGGTCCAATGT GGGTAGGGCTGTTCTGATGA 165
22 Collagen VI alpha 1 ACAGTGACGAGGTGGAGATCA GATAGCGCAGTCGGTGTAGG 122
23 Collagen IV alpha 2 TTGGCGGGTGTGAAGAAGTTT CCTTGTCTCCTTTACGTCCCTG 178
24 IL-1B GGGCCTCAAGGAAAAGAATC TTCTGCTTGAGAGGTGCTGA 205
25 Fibronectin 1 GCAGTAACCACTATTCCTGCAC TCCTGATACAACCACGGATGAG 192
26 T-cell differentiation
protein 2 (MAL2)
TTGCCTCCTCCAATGTTCCTC CAGTTAGCATCAATTTGAGCCAC 133
27 CTGF CAGCATGGACGTTCGTCT CCAACCACGGTTTGGTCCTT 117
28 SPARC (osteonectin) CGAGACCTGTGACCTGGACAATG TCCGGTACTGTGGAAGGAGTGG 127
29 Sflt-F TGAGCACTGCAACAAAAAGG TCCTCCGAGCCTGAAAGTTA 172
30 FLT-F GGCTCTGTGGAAAGTTCAGC GCTCACACACTGCTCATCCAAA 223
31 FGFR1, transcript
variant 2 mRNA
TCCAGTGCATCCATGAACTCT CTGTTGCGTCCGACTTCAA 268
32 Brain derived nerve
growth factor
GATGCTCAGTAGTCAAGTGCC GCCGTTACCCACTCACTAATAC 168
33 Chemokine (C-C
motif) ligand 2
CAGCCAGATGCAATCAATGCC TGGAATCCTGAACCCACTTCT 190
34 Chitanase 3 like 1 GAAGAGGCCCTGTCTAGGTA AGATGATGTGGGTACAGAGG 250
35 Matrix Metallo
proteinase 2 (MMP2)
CCGTCGCCCATCATCAAGTT CTGTCTGGGGCAGTCCAAAG 169
36 Interleukin 1 aplha
(IL-1A)
TGTGACTGCCCAAGATGAAG CGCCTGGTTTTCCAGTATCT 238
37 Decorin AGTTGGAACGACTTTATCTGTCC GTGCCCAGTTCTATGACAATCA 160
38 Neurotrophin
tyrosine kinase
receptor 2
GATAAGCTGGACTCGGCACG GGACGACATCCCTAGCAGCC 152
39 Connexin 43 TGTCCTTAAGTCCCTGCTAA GTAGCTGAGGAATGATGAAAAAG 245
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1230The analysis of MC-L and MSC-BM showed similar and
differential gene expression between the two cells. Various
gene ontology terms were picked up and analyzed from the
microarray data. The gene ontology terms were classified into
groups like osteogenic, chondrogenic, myoblast, adipogenic,
MHC-class II related, Homeobox genes, extracellular, and
other genes (Table 4).
Validation of microarray using semi quantitative RT–PCR
and Real-time PCR: To validate the gene expression profiles
determined by the microarray analysis, the expression levels
of selected genes were analyzed by real time PCR (10 genes;
Figure 3) and semi quantitative RT–PCR (28 genes, Figure
4).  The  gene  expression  patterns  obtained  by  the  two
techniques  were  in  good  agreement  with  that  from  the
microarray analysis, indicating high fidelity in microarray
data and analytical methods.
DISCUSSION
Limbal stem cell deficiency has been a challenging clinical
problem, the current treatment of which involves replenishing
the depleted limbal stem cell pool by either limbal tissue
transplantation or use of cultivated limbal epithelial sheets
[1-3,24]. As described in our earlier publications [25,26], we
established a feeder cell free method of cultivating the limbal
explant tissues on denuded human amniotic membrane. Our
results show that limbal explant culture derived MC-L when
expanded exhibit a spindle shaped, fibroblast-like appearance
similar to that of MSC-BM [17]. Though we had no logical
explanation  for  this  in  the  beginning,  the  revelation  of
presence of spindle cells prompted us to postulate that these
spindle  cells  in  the  explant  culture  system  function  like
“intrinsic feeder cells.” To the best of our knowledge and
literature search this is the first study that characterizes the
cultured cells (LEC as well as MC-L) from the limbal explant
culture, which are directly used for translational research in
humans. Isolated MC-L can be distinguished from epithelial
cells (lack of expression of KRT3/12, KRT14), fibroblasts
(lack of expression of HLA-DR), hematopoietic stem cells
(lack of expression of CD34, CD45, CD11b, CD10, CD40,
Figure 1. Morphological features of mesenchymal cells of limbus. Limbal explant cultures having epithelial (E) and mesenchymal cells (S;
200×; A). Cell sphere formation in the MC-L cultures giving impression of embryoid body formation (200×; B). Spindle shaped morphology
of MC-L forming colonies (200×; C). Culture of MC-L showing both spindle shaped and broad flattened cells (arrows; 200×; D)
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1231Figure  2.  Characterization  of  limbal  explant  culture  derived  epithelial  (LEC)  and  mesenchymal  like  cells  (MC-L).  Following
immunoctytochemical analysis (A-L) epithelial cells showing positive for ABCG2 (A), CK3/CK12 (B; green fluorescence), CK19 (C; red
fluorescence), CK14 (D), E-Cadherin (E), vimentin (F; green fluroscence), double immunostaining for PAX-6 (green fluorescence) and
vimentin (red fluorescence; G). Mesenchymal like cells of limbus (H-L) showing positive for vimentin (H) and negative for cytokeratin 3/12
(I), cytokeratin 14(J), CD34 (K), and nestin (L). Nuclear staining was performed with propidium iodide (red; A, B, D, E, H-L). Scale bar=20
µm (A-C, E-H, and J) and 10µm (D, I, K, L). Flow cytometry analysis (M-V) was performed by incubation of the mesenchymal like cells
of limbus with the indicated antibodies. M: Isotype controls for FITC and PE, N: CD90 FITC and CD44 PE, O: CD40-FITC and HLA-ABC
PE, P: CD11b FITC and HLA-ABC PE, Q: CD34 FITC and CD10 PE R: Isotype control for FITC and APC, S: CXCR4 APC and CD90
FITC, T: CD40L APC and CD40 FITC, U: Isotype control for FITC and PerCP, V: CD138 PerCP and CD13 FITC.
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1232CD40L, and CD138), because they are adherent to the surface
of  tissue  culture  flasks  and  express  different  cell-surface
markers (CD90, CD13, CD105, and CD44).
Genes that show differential expression in the LEC when
compared  to  MC-L  and  MSC-BM,  encode  proteins  that
stabilize epithelial sheets and promote or regulate cell to cell
interaction and cell to matrix interaction including keratins
(Keratin  13,  Keratin  12),  laminins  (LAMA3,  LAMB3),
cadherins (CDH3 and CDH1), nebulette, epiregulin, calbindin
1 28 kDa, desmosomal components (DSG3, DSC2), matrix
metallo peptidase 10, Serine peptidase inhibitor clade B5, and
carcinoembryonic antigen-related cell adhesion molecule 1.
In addition, LEC showed high expression of known basal
markers (TP73L [p63], ITGA6, epiregulin, and HOP) and
differentiated  epithelial  markers  (CDH1,  KRT12)  [27].
Immunocytochemical  analysis  showed  the  expression  of
limbal  epithelial  stem  cells  markers  ABCG2,  vimentin,
KRT14, and KRT19 and also expressed the differentiated
epithelial markers CDH1 and KRT3/12 on cultivated LEC.
This further supports the fact that cultivated LEC cells on
dhAM  in  a  feeder  cell-  free  culture  technique,  contain  a
distinct population of stem cells and differentiated cells which
serve  to  replenish  the  depleted  limbal  stem  cells  when
transplanted to the diseased eye [1,2,25]. Some of the high
expressed  transcripts  in  the  limbal  epithelial  cell  cultures
include  CD24,  a  surface  molecule  that  has  been  used  to
identify different types of human stem cells [28]; OTX1, a
transcription factor is expressed in the presumptive ciliary
body  and  iris  and  has  been  shown  to  be  essential  for
development  of  these  tissues  [29],  and  FOXA1,  an
endodermal stem cell marker [30]. While it could be critically
argued that the study does not represents the specific signature
of  the  limbal  stem  cells  alone,  this  data  are  valuable  in
contribution to data on entire population of cultured limbal
epithelial cells that are used for clinical transplantation. This
further supports strong evidence that the cultivated LEC cells
contain a distinct population of stem cells and differentiated
cells which serve to replenish the depleted limbal stem cells
when  transplanted  to  the  diseased  eye  –  it  represents  the
TABLE 2. THE DIFFERENTIAL GENE EXPRESSION BETWEEN LEC, MC-L AND MSC-BM, AS MEASURED BY THE FOLD CHANGE DIFFERENCE OF THE
CORRESPONDING GENES (RIBOSOMAL GENES EXCLUDED). ABBREVIATIONS: LEC – LIMBAL EPITHELIAL CELLS, MC-L – MESENCHYMAL LIKE CELLS
OF LIMBUS, MSC-BM – MESENCHYMAL STEM CELLS OF BONE MARROW.
Genes differentially expressed in LEC (25 fold overexpression in LEC compared MC-L and MSC-BM)
Keratin 12, T-cell differentiation protein 2 (MAL2), Nebulette, v-myc myelocytomatosis viral related oncogene, ets homologous factor,
calbindin 1, Kringle containing transmembrane protein 2, glucosaaminyl (N-acetyl) transferase 2, carcinoembryonic antigen-related cell
adhesion molecule 6, Apolipoprotein B mRNA editing enzyme catalytic polypeptide –like 3a, tumor associated calcium signal transducer
1, sciellin, serine peptidase inhibitor kazal type 5, carcinoembryonic antigen-related cell adhesion molecule 1, interleukin 1 alpha, interleukin
18, dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1), Transmembrane channel-like 5, claudin 1, defensin beta 1, WAP
four-disulfide core domain 5, chemokine (C-X-C motif) ligand 1, dystonin, desmocollin 2, cadherin 1, transforming growth factor alpha,
S100 calcium binding protein A8, Serpin peptidase inhibitor clade B member 5, visinin-like 1, interleukin 1 beta, desmoglein 3, matrix
metallopeptidase 10, tumor protein p73-like (p63), homeoboxdomain-only protein (HOP), amphiregulin.
Genes differentially expressed in MC-L (15 fold overexpression in MC-L compared to LEC and MSC-BM)
Vascular endothelial growth factor receptor 1, cadherin 6, forkhead box F1, glutamate receptor ionotrophic, collectin sub-family member
12, SHC (Src homology 2 domain containing) transforming protein 3 (SHC3), AF052115, BC073929.
Genes differentially expressed in MSC-BM (20 fold overexpression in MSC-BM compared to LEC and MC-L)
growth differentiation factor 6 (GDF6), Urea transporter, erythrocyte (SLC14A1), neurotrophic tyrosine kinase, receptor, type 2 (NTRK2),
early growth response 2 (Kro × −20 homolog, Drosophila) (EGR2), secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-
lymphocyte activation 1) (SPP1), myogenic factor 6 (herculin) (MYF6), collagen, type XI, alpha 1 (COL11A1), olfactomedin 4 (OLFM4),
hepatitis A virus cellular receptor 2 (HAVCR2), homeo box A11, antisense (HOXA11S) on chromosome 7, homeobox C9 (HOXC9),
HELAD1S mRNA for helicase, phosphodiesterase 1C, calmodulin-dependent 70 kDa, opioid binding protein/cell adhesion molecule-like
(OPCML), transcript variant 2, zinc finger, matrin type 4 (ZMAT4),
Genes differentially expressed in limbal explant culture derived cells (LEC and MC-L) over bone marrow (10 fold difference)
semaphorin 3D (SEMA3D), matrix metallopeptidase 1 (interstitial collagenase) (MMP1), vitrin (VIT), Lysophosphatidic acid receptor Edg-7
(LPA receptor 3) (LPA-3), keratin 18 (KRT18), transcript variant 1, insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3), myelin
basic protein (MBP), contactin 3 (plasmacytoma associated) (CNTN3),
Genes differentially expressed in MC-L, MSC-BM over epithelial cells (over 20 fold difference)
nucleosome assembly protein 1-like 3 (NAP1L3), thymocyte selection-associated high mobility group box (TOX), axin 2 (conductin, axil)
(AXIN2), phosphodiesterase 11A (PDE11A), potassium voltage-gated channel, Isk-related family, member 4 (KCNE4), dermatan sulfate
epimerase-like (DSEL), chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1), G protein-coupled receptor 124 (GPR124),
protocadherin 18 (PCDH18), hyaluronan and proteoglycan link protein 1 (HAPLN1), collagen, type V, alpha 2 (COL5A2), alpha-2-
macroglobulin (A2M), decorin (DCN), cerebellar degeneration-related protein 1, 34 kDa (CDR1), ependymin related protein 1 (zebrafish)
(EPDR1), formin 2 (FMN2), Platelete derived growth factor receptor alpha, frizzled homolog 7, dapper, antagonist of beta-catenin, homolog
3, microfibrillar associated protein 5, lysyl oxidase, integrin, alpha 8, junctional adhesion molecule 2, protein kinase C, alpha, platelet-derived
growth factor receptor, beta polypeptide.
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1233signature of cultured limbal cells inclusive and not exclusive
of stem cells.
Cytokine and growth factor signaling is an important
determinant of the functional state of these cells and therefore
we evaluated this relationship between LEC and MC-L [15].
TABLE 3. DIFFERENTIAL GENE EXPRESSION BETWEEN LEC AND MC-L IN GROWTH FACTORS AND CYTOKINE RELATED GENES.
Gene LEC versus MC-L LEC versus MSCBM MC-L versus MSCBM
amphiregulin (schwannoma-derived growth factor) (AREG) 167.6 (Down) 131.25 (down) 3.74 (down)
transforming growth factor, alpha (TGFA) 57.21 (down) 28.49 (down)  
fibroblast growth factor binding protein 1 (FGFBP1) 38.75 (down) 23.011 (down)  
fms-related tyrosine kinase 1 (vascular endothelial growth
factor/vascular permeability factor receptor) (FLT1)
31.0 (up)   96.42 (down)
Platelet derived growth factor receptor alpha (PDGFRA) 26.10 (up) 33.93 (up)  
platelet-derived growth factor receptor, beta polypeptide
(PDGFRB)
20.52 (up) 21.90 (up)  
insulin-like growth factor binding protein 5 (IGFBP5) 17.65 (up) 14.81 (up)  
growth factor receptor-bound protein 14 (GRB14) 17.23 (down) 5.82 (down) 2.95 (down)
fibroblast growth factor 2 (basic) (FGF2) 13.78 (up)    
fibroblast growth factor 11 (FGF11) 12.83 (down)    
keratinocyte growth factor-like protein 1 (KGFLP1) 10.9 (up)   9.85 (up)
fibroblast growth factor receptor 1 (fms-related tyrosine
kinase 2, Pfeiffer syndrome) (FGFR1)
10.50 (up) 8.96 (up)  
insulin-like growth factor 2 (somatomedin A) (IGF2) 9.9 (up) 6.2 (up)  
connective tissue growth factor (CTGF) 9.77 (up) 15.45 (up) 2.3 (up)
pleiotrophin (heparin binding growth factor 8, neurite
growth-promoting factor 1) (PTN)
8.54 (up) 9.9 (up)  
insulin-like growth factor 2 mRNA binding protein 1
(IGF2BP1)
8.10 (up)    
fibroblast growth factor 1 (acidic) (FGF1) 8.03 (up) 5.41 (up) 7.41 (down)
Insulin-like growth factor binding protein 4 (IGFBP4) 7.65 (up) 14.2 (up) 2.96 (up)
fibroblast growth factor 7 (keratinocyte growth factor)
(FGF7)
7.51 (up) 15 (up) 4.51 (up)
platelet derived growth factor D (PDGFD) 5.97 (up) 12.7 (up)  
fibroblast growth factor binding protein 3 (FGFBP3) 5.68 (up) 4.4 (up)  
insulin-like growth factor binding protein 5 (IGFBP5) 5.61 (up) 5.4 (up) 2.95 (down)
fibroblast growth factor receptor 2 (fgfr2) 4.50 (down)   4.89 (up)
Hepatocyte growth factor precursor (Scatter factor) (SF)
(Hepatopoeitin-A)
4.05 (up) 10.06 (up)  
transforming growth factor beta 1 induced transcript 1
(TGFB1I1), transcript variant 2
3.94 (up) 2.97 (up)  
nerve growth factor, beta polypeptide (NGFB) 3.83 (up)   2.6 (down)
chemokine (C-X-C motif) ligand 2 (CXCL2) 79.06 (down) 4.5 (down)  
chemokine (C-X-C motif) ligand 3 (CXCL3) 26.25 (down) 16.0 (down) 3.88 (up)
chemokine (C-X-C motif) ligand 1 (CXCL1) 65.87 (down) 64.9 (down)  
chemokine (C-X-C motif) ligand 11 (CXCL11) 58.344 (down) 14.42 (down)  
chemokine (C-X-C motif) ligand 10 (CXCL10) 7.71 (down) 6.97 (down)  
chemokine (C-X-C motif) ligand 12 (stromal cell-derived
factor 1) (CXCL12)
34.26 (up) 82.68 (up)  
chemokine (C-C motif) ligand 26 (CCL26) 11.4 (up) 2.49 (up)  
chemokine (C-C motif) ligand 2 (CCL2) 23.43 (up)   3.48 (down)
chemokine (C-C motif) ligand 13 (CCL13) 12.42 (up)   2.34 (up)
interleukin 1, alpha (IL1A) 78.72 (down) 63.61 (down)  
interleukin 1, beta (IL1B) 48.57 (down) 28.89 (down)  
interleukin 1 receptor, type II (IL1R2) 12.17 (down) 21.03 (down) 3.92 (up)
interleukin 1 receptor antagonist (IL1RN) 20.06 (down) 15.10 (down)  
interleukin 20 receptor, alpha (IL20RA) 210.69 (down)    
interleukin 18 (interferon-gamma-inducing factor) (IL18) 78.26 (down) 56.72 (down)  
interleukin 23, alpha subunit p19 (IL23A) 28.40 (down) 29.29 (down)  
interleukin 11 receptor, alpha (IL11RA) 15.58 (up)    
neurotrophin 5 (NTF5) 14.96 (down) 11.64 (up)  
neurotrophin 3 (NTF3) 16.40 (up) 7.50 (up) 7.48 (down)
nerve growth factor, beta polypeptide (NGFB) 3.8 (up)    
Glial cell line-derived neurotrophic factor precursor
(Astrocyte- derived trophic factor 1)
4.24 (up) 6.56 (up)  
GDNF family receptor alpha 1 (GFRA1) 6.5 (up) 6.28 (up)  
brain-derived neurotrophic factor (BDNF) 9.15 (up) 3.69 (up) 8.68 (down)
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1234TABLE 4. COMPARISONS OF GENES EXPRESSED IN MC-L AND IN MSC-BM CELLS FOR SELECTED TERMS OF GENE ONTOLOGY.
ABBREVIATIONS: LEC – LIMBAL EPITHELIAL CELLS, MC-L – MESENCHYMAL LIKE CELLS OF LIMBUS, MSC-BM – MESENCHYMAL STEM
CELLS OF BONE MARROW. ALL THE GENES ARE HIGHLY EXPRESSED (UP) EXCEPT THOSE IN BRACKETS (DOWN).
Gene Name LEC versus MC-L LEC versus MSC-
BM
MC-L-MSC-BM
Osteogenesis
Osteonectin 5.8 3.89  
Collagen, type I, alpha 2 10.7 10.15  
Connective tissue growth factor 9.7 15.45  
Collagen, type V alpha 2 16.7 22.2  
Osteopontin   3.8 29.4
Runt related transcription factor 2   5.9 5.5
PDZ and LIM domain 7, transcript variant 4 5.3 3.29  
Gremlin 2 16.1 14.29  
Myogenesis
Transgelin 4.2 5.31  
Meltrin alpha 10 13.78  
Myosin light chain 9, transcript variant 2 4.7 4.87  
Synocoilin 1 8.2 5.7  
Tropomyosin1 (alpha), transcript variant 3 4.7 6.84  
Tropomyosin 2 (beta), transcript variant 2 3.5 3.75  
Caldesmon 1, transcript variant 1 13.8 17.7  
Desmuslin, transcript variant A 26.4 27.9  
Leiomodin 1 8.5 9.29  
Adipogenesis
Leptin Receptor 4.94 60.58 26.74
Leptin   6.24 6.89
Serum amyloid A1, Transcript variant 1 6.8 (down) 4.2 (down) 7.7
CCAAT/enhancer binding protein alpha 4.8 (down)   3.23
Chondrogenesis
Fibromodulin 10.1 13.82  
Decorin, transcript variant A1 27.6 41.45  
Cartilage oligomeric matrix protein   8.4 11.15
Tensin 1 14.9 10.31  
Hyaluronan and proteoglycan link protein 31 47.45  
Collaten, type XI, alpha 1   60.18 46.12
Chitanase 3-like 1   4.72 5.68
Extracellualr Matrix Components
Microfibrillar associated protein 5 24 28.12  
Syndecan 2 12.1 16.7  
Matrix-remodelling associated 5 11.3 7.2  
Chondroitin sulfate proteoglycan 4 8.3 7.5  
Collagen, type VIII, alpha 1, transcript variant 1 8.6 5.39  
Others
Procollagen-lysine 1,2-oxoglutarate 5-dioxygenease 1 3.2 3.3  
Low density lipoprotein-related protein 12 3.43 3.3  
Notch homolog 2 3.78 5.2  
Collagen, type VI alpha 1 3.9 2.39  
Cysteine-rich, angiogenic inducer, 61 4 4.8  
Glial cell line-derived neurotrophic factor precursor 4.2 6.5  
Endoglin 4.29 4.17  
Collagen, type 1, alpha 2 4.3 3.3  
Leukemia inhibitory factor receptor alpha (LIFR) 4.46 5.9  
Neuropilin 1 4.6 4.1  
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1235The  most  important  growth  factors  for  normal  human
keratinocyte  proliferation  are  member  of  EGF  family,
including TGFA, HB-EGF, ER, and AR and these act in an
autocrine  manner  [31].  Our  data  also  reveals  the  high
expression of these four EGF members in LEC. The fibroblast
growth  factors,  FGF1  and  FGF2,  are  well  characterized
growth factors known for their mitogenic effect on several
cells derived from neuroectodermal or mesodermal origins.
FGF1 and FGF2 (mitogenic to corneal and limbal epithelium)
[32], keratinocyte growth factor (FGF7), epithelium specific
growth factor (mitogen for several epithelial cells including
limbal epithelial cells) [15] were highly expressed in MC-L.
Interestingly, and as expected, their corresponding receptors
FGFR1 were expressed in MC-L and FGFR2 in LEC. The
proinflammatory forms of IL-1 (IL1A and IL1B) expression
in LEC play significant roles in ocular surface immune and
inflammatory responses and wound healing [33]. The highly
expressed chemokine observed in LEC include CXCL1, 2, 3,
10, and 11 and in MC-L include CXCL12, CCL26, CCL2, and
CCL13. The intense expression of chemokine ligand CXCL12
(Stromal cell derived factor 1) in MC-L is similar to the study
by  Tristan  and  coworkers  [34].  This  factor  might  exert
physiologic effects on the cornea and could be involved in
pathological conditions such as corneal angiogenesis [34].
The neurotrophic factors have been reported to play important
roles in maintaining stem cells in the limbus [35]. We also
noted  a  high  expression  of  neurotrophic  factors  like
neurotrophin 3, nerve growth factor and brain derived growth
factor in MC-L while neurotrophin 5 was highly expressed in
LEC.  Glial  derived  neurotrophic  factor  (GDNF)  and  its
receptor GDNF receptor alpha 1 were highly expressed in the
MC-L and MSC-BM similar to the observations made by Qi
and coworkers in limbal cells [35]. All these features support
our hypothesis that the limbal epithelial cells and stromal cells
play a complementary role not only in vivo but also in vitro
in the explants culture system.
Genes highly expressed (Table 2) in MC-L include fetal
kidney cadherin (CDH6), vascular endothelial growth factor
receptor 1 (VEGFR1 or FLT1) glutamate receptor ionotrophic
(GRIA3), collectin subfamily member 12, transcription factor
forkhead box F1 (Foxf1), src homology 2 domain contataining
transforming  3  (SHC3),  oxytocin  receptor,  and  unknown
genes AFO52115 and BCO73929. These genes with such
higher expression (>15 fold) can be considered as the markers
of  mesenchymal  like  cells  of  limbus.  The  FOXF1  is  a
transcription factor which is expressed in mesenchymal cells
of the lung, liver and gall bladder and is shown to be involved
in  mesenchymal  cell  migration  without  changes  in  cell
proliferation and cells survival [36].
An interesting observation was the high expression of
receptors  neurophilin  1,  platelet  derived  growth  factor
receptor alpha, and leprecan-like 2 in MC-L, which is similar
to MSC-BM [37]. This study supports the characteristics of
mesenchymal  cells  (MSC-BM,  and  MC-L)  that  were
previously identified in MSCs, such as vimentin, fibronectin,
collagen  Type  I  and  III,  collagen  type  VI,  light  chain  of
myosin 9, and matrix metallopeptidase 2 [37-40]. The genes
which show similar gene expression in MC-L and MSC-BM
are those which are related to extracellular components, cell
adhesion  molecules  (microfibrillar  associated  protein  5,
TABLE 4. CONTINUED.
Gene Name LEC versus MC-L LEC versus MSC-
BM
MC-L-MSC-BM
Colony stimulating factor 1 (Macrophage) 5.6 15.09  
Wingless-type MMTV integration site family, member
5B
5.7 6.06  
Neuronal growth regulator 1 6.13 8.06  
Noggin 6.2 3.7  
Matrix metallopeptidase 2 6.27 6.2  
Collagen, type VI, alpha 3, transcript variant 4 6.27 8.4  
Neuronal PAS domain protein 1 6.38 5.7  
Fibroblast growth factor receptor 1 6.45 8.9  
Neuropilin 1, transcript variant 1 6.7 8.3  
Collagen, type VI, alpha 2 7.4 6.2  
Collagen, type VI, alpha 1 8.0 10.2  
Bone marrow stromal cell antigen 8.2 8.4  
Collagen, type V, alpha 1 8.4 9.3  
Fibronectin 1, transcript variant 7 9.24 10.14  
Fibroblast growth factor receptor 1, transcript variant 1 10.5 7.6  
Collagen, type 1 alpha 2 10.7 10.15  
Angiopoietin 1 14.8 17.1  
Neuronal cadherin 8.4 13.5  
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1236syndecan  2,  matrix-remodelling  associated  5,  chondroitin
sulfate proteoglycan 4, and collagen 8 alpha 1) and the genes
related to osteoblasts (osteonectin, collagen type 1, connective
tissue  growth  factor,  and  OB-cadherin),  chondrocytes
(fibromodulin,  decorin,  tensin  1,  hyaluronan,  and
proteoglycan  link  protein)  and  myoblasts  (transgelin,
sarcoglycan  epsilon,  caldesmon  1,  leimodin,  and  meltrin
alpha;  Table  4).  The  MC-L  also  expressed  the  products
characteristics of hematopoiesis-supporting stroma, including
fibulin-1, fibulin 2, collagen type VI, and stromal cell-derived
factor, in the same level as MSC-BM thus supporting our
hypothesis that these cells possibly act as intrinsic feeder cells
Figure 3. Validation of microarray data by Real time RT–PCR. The individual gene-specific values thus calculated were averaged to mean
±standard deviation and fold change was expressed as log 2 ratios (y-axis).
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1237Figure 4. Validation of micro array data
by semiquantitative RT–PCR. Reverse
transcription polymerase chain reaction
analysis  of  the  selected  differentially
expressed  genes.  Ribosomal  protein
large  35  (RPL35)  was  served  as  an
internal control. Abbreviations: LEC –
limbal  epithelial  cells,  MC-L  –
mesenchymal cells of limbus, MSC-BM
–  mesenchymal  stem  cells  of  bone
marrow, -RT – no reverse trasncriptase,
CDH1  –  cadherin  1  (E-cadherin),
COLVIA1  –  collagen  6  alpha  1,
COL4A2 – collagen 4 alpha 2, IL-1B –
interleukin 1 beta, FN1 – fibronectin 1,
MAL2 - T-cell differentiated antigen 2,
CTGF  –  Connective  tissue  growth
factor,  FGFR1  –  fibroblast  growth
factor receptor 1, BDNF – brain derived
nerve growth factor, CCL2 – chemokine
ligand 2, CHI3L1 – chitanase 3 like 1,
MMP2  –  matrix  metallo  peptidase  2,
IL1A  –  interleukin  1  alpha,  KRT7-
cytokeratin 7, DCN – decorin, Ang 1 –
angiopoientin, bFGF – basic fibroblast
growth factor, NTRK2 – neurotrophin
tyrosine kinase receptor 2.
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1238or nurture cells in explant culture system. Nevertheless, some
differences  were  observed  between  expression  profiles  of
MC-L and MSC-BM. Among the genes that were exclusively
or  expressed  at  higher  levels  by  MSC-BM  are  growth
differentiation factor 6, neurotrophic tyrosine kinase receptor
2, urea transporter erythrocyte, and myogenic factor 6. Other
genes highly expressed at higher levels in MSC-BM include
chondrogenesis  related  genes  (cartilage  oligomeric  matrix
protein, collagen 11 alpha 1, and chitinase 3 like 1), osteogenic
related  genes  (runt  related  transcription  factor  2  and
osteopontin) and adipogenic related genes (CCAAT/enhancer
binding  protein  alpha,  leptin,  and  Serum  amyloid  A1
transcript variant 1). The MSC-BM are more committed to the
osteoblastic,  chondrogenic  and  adipocytic  lineages.  This
suggests that in addition to some common signatures of niche
supporting cells, mesenchymal cells from different sources
possibly carry tissue specific signatures, which reflect their
tissue of origin. The limitations of study would be the sample
size used for microarray (n=2) and potential contamination of
stromal cells in limbal epithelial cells cultures.
In summary, this study highlights the gene expression
profile of cultivated limbal epithelial cells, mesenchymal cells
from  limbal  stroma  obtained  from  an  ex-vivo  expanded,
feeder cell-free, limbal explant tissue culture system. Their
lineage  specific  signatures,  evidence  of  interdependent
pathways with limbal epithelial cells, striking resemblance to
the  signature  of  bone  marrow  derived  mesenchymal  cells
support our hypothesis that the limbal stromal cells act like
intrinsic  feeder  cells  or  the  nurture  cells,  similar  to  bone
marrow derived mesenchymal cells and could possibly be an
important component of limbal niche.
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